The CEO of Health and Happiness (H&H) Group has revealed how its baby nutrition products are booming in China and further afield, underlined Swisse’s ambitious international expansion plans, but acknowledged there were some supply chain risks amid...
China’s nicotinamide mononucleotide (NMN) supplier EffePharm is embarking on its first human clinical trial as it seeks to validate the anti-ageing effects and safety of its ingredient “Uthever”.
This round-up focuses on the vitamin C sales surge in China due to COVID-19, the addition of three 'blue-hat' probiotics formulation to Sirio Pharma and more.
The COVID-19 epidemic has led to a rebound in demand for plant extracts with immune-boosting effects, but a China industry expert has warned there are difficulties in exporting the goods due to logistic supply chain problems.
Chinese health foods giant BY-HEALTH's FY19 revenue jumped 20.94% to hit RMB$5.2bn (US$748m), however performance from its Australian subsidiary Life-Space failed to meet expectations due to changes in China’s e-commerce law.
Sirio Pharma has obtained the ‘blue-hat’ approval for three of its probiotic formulations. The company now has ‘blue-hat’ certificates for four of its probiotic formulations in total.
Chinese e-commerce giant, JD has reported that sales of vitamin C dietary supplements on its platform were up five-fold, after the announcement of the novel coronavirus (COVID-19).
Authorities from a raft of countries have stepped out to caution against the advertising of health supplements that claim to prevent or treat the novel coronavirus.
In this round-up, we shine the spotlight on major brands, including Unilever with its launch of gummy vitamin brand ‘OLLY’ in Singapore, Megmilk Snow Brand’s launch of its first functional yogurt drink and more.
Tea consumption could reduce the risks of atherosclerotic cardiovascular disease (ASCVD) and mortality, especially among consistent habitual tea drinkers.
In this round up of industry trends, we look at how Danone has incorporated its infant formula products with a dual-QR code for traceability purpose, how COVID-19 spread has led to a spike in demand for vitamins in Singapore, as well as the trends and...
Australia's goat milk specialist Nuchev says that the increasing number of goat milk brands competing in China - one of its key markets post-IPO - will benefit instead of posing a threat to its business.
Danone is launching a new traceability service for its infant formula in China, followed by other Asia-Pacific markets as well as Australia and New Zealand throughout the year.
The a2 Milk Company said revenue from China was “above expectations” in Jan and Feb, but the ongoing COVID-19 outbreak had brought uncertainty to consumer demand and supply chain.
Probiotics for managing constipation in children, a Singapore company’s innovation in lab-grown breast milk, and Nestle Health Science China’s two new FSMPs products are some of the most read stories on the social media.
Blackmores is targeting China’s ‘modern career women’ and building an innovation centre to arrest the slump in its sales in the country, while also unveiling ambitious plans for Indonesia, Australia, and a marketing testing project for India.
Seven-out-of 10 online shopping complaints received by Beijing Internet Court from September 2018 to October 2019 were related to food and health food products.
In this round-up, we look at the recent regulatory development in the health and nutrition industry in APAC, including the Chinese authorities’ drafted plans for changing the current infant food safety standards.
The Chinese authorities are conducting a public consultation for the new food safety standards that it has drafted for a number of food items, including liquid infant formula, infant formula powder, and infant food.
Kappa Bioscience is venturing into the vitamin K2 milk category in China, on top of its existing vitamin K2 nutraceutical business, after its synthetic-origin vitamin K2 MK-7 (menaquinone-7) was approved by China authorities for use in mother and children...
Ali Health has identified four key health products purchase trends, as well as the best-selling products, witnessed across the Chinese New Year period.
This round up provides a glimpse on how direct-selling firms in China are adopting new retail models, how H&H plans to expand its kids nutrition portfolio, the impact of the Covid-19 on businesses, and GNC’s blue-hat products.
Supplement manufacturers and suppliers in China sought return to normalcy as they resume operations as the extended Chinese New Year holiday – lengthened by the novel coronavirus outbreak – comes to an end.
Australian freeze-dried supplement company Vmores is planning to launch its beauty, women’s and gut health products in China from March, before entering other markets across Asia.
A number of Chinese health food firms have seen an increase in demand for products related to immunity boosting and respiratory health amid the Wuhan virus outbreak.
Health & Happiness (H&H) Group’s Good Gout is focusing on its China expansion this year, with new product launches and more offline distribution channels in the pipeline for the firm which specialises in organic snacks for children.
The US-China trade deal has lowered trade barriers for the US in areas such as the infant formula sector, but industry observers remain conservative on the potential benefits, citing unanswered questions in how the deal would actually work and international...
Some of the major brands making new moves in recent weeks were Nestlé Health Science China with its newly launched Food for Special Medical Purposes (FSMP) brands, GNC entering China pharmacy chains with its four 'blue-hat' products, and how...
See January's 10 most read stories, including the trends and predictions that industry experts have made about the health and nutrition market for this year, Dr Reddy's foray into the nutrition business with its new product for diabetic patients...
Two of Nestlé Health Science China’s infant nutrition products for youngsters with cow’s milk allergies have obtained Food for Special Medical Purposes (FSMPs) status in the country.
Goat infant formula was the "most profitable" segment for Bubs Australia in the last quarter, up 118%, with its home market performing well amid a sales decline in China.
The ongoing China Coronavirus outbreak has affected a number of nutrition retailers which rely on Chinese tourists as a key revenue stream, with some putting on hold new plans and adopting a ‘wait and see’ approach.
Several health and nutrition firms are showing their support for China’s fight against the deadly novel coronavirus in the form of cash, protective outfits, and nutrition products.
